CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2 Randomized, Single-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of the Combination of Famotidine and Celecoxib as a Treatment in Moderate-to-severe Patients Hospitalized for COVID-19

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05085574
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:32.293548+00:00
Published At: 2023-10-10T00:00:00+00:00
Record Updated At: 2023-10-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["2019 Novel Coronavirus Disease", "2019 Novel Coronavirus Infection", "2019-nCoV Disease", "2019-nCoV Infection", "COVID-19 Pandemic", "COVID-19 Virus Disease", "COVID-19 Virus Infection", "Covid19", "Coronavirus Disease 2019", "SARS-CoV-2 Infection", "SARS-CoV-2 Acute Respiratory Disease", "COVID-19"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-10-10"
protocolSection.identificationModule.nctId: "NCT05085574"
protocolSection.identificationModule.officialTitle: "A Phase 2 Randomized, Single-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of the Combination of Famotidine and Celecoxib as a Treatment in Moderate-to-severe Patients Hospitalized for COVID-19"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.